BioSpace News Archive

Champions Oncology, Inc. (Nasdaq: CSBR), engaged in an end-to-end range of research and development technology solutions and services to improve the development and use of oncology drugs, today announced that management will participate at the Janney Montgomery Scott Healthcare Conference 2018 on Monday, September 17th in New York.

PMI BioPharma Solutions has established complete research and manufacturing operations at multiple sites located in both Nashville and Celina Tennessee.

During its annual event, Utah Business recently unveiled their list of Utah state’s fastest growing companies. The Fast 50 placed eAssist Dental Solutions (https://dentalbilling.com/) at number 27, securing the dental billing service’s continued reputation as a unique problem solver for modern dental practices.

PatientKeeper®, Inc. and MEDHOST®, Inc. today announced that they have entered a reseller agreement under which MEDHOST will be able to offer its hospital customers and prospects PatientKeeper’s physician workflow software tightly integrated with MEDHOST’s inpatient electronic health records (EHR) solution.

The World’s Only Biodegradable Biliary/Pancreatic Stent was CE Mark Approved in June 2018.

Innomane Inc. announces today the Health Canada approval and Canadian launch of Diaronex®, a natural and herbal remedy made from the herb Holarrhena, which is recognized by World Health Organization to help relieve diarrhea.

According to a report published by Progressive Markets, the cancer immunotherapy market was valued at USD 57.2 Billion in 2017 and is expected to reach USD 166.7 Billion by 2025 while growing at a compound annual growth (CAGR) of 14.42%.

According to a report published by Hexa Research, the U.S. medical cannabis market size was valued at USD 5.44 Billion in 2016 and is anticipated to reach USD 19.48 Billion by 2024.

CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced it has received a milestone payment of $250,000 (USD) from Orphazyme A/S (CPH: ORPHA).

CIT Group Inc. (NYSE: CIT) today announced that its Healthcare Finance business served as administrative agent and lead arranger for $115 million first lien credit facility and sole lead arranger for a $29 million second lien credit facility on behalf of Bristol Hospice LLC to finance the acquisition of two additional hospice providers and provide ongoing working capital.